Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
Pantherics has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2022.
Pantherics's investors include National Institutes of Health, UWM Research Foundation.
Pantherics is headquartered in Milwaukee, United States.
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
Pantherics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pantherics — Funding & Investors." VCBacked, August 10, 2022, https://www.vcbacked.co/company/pantherics. Accessed July 19, 2026.
VCBacked. (2022). Pantherics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/pantherics
{{cite web |title=Pantherics — Funding & Investors |url=https://www.vcbacked.co/company/pantherics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated